Drug intelligence / Profile preview

Fantom Encore

Development stage: Unknown
Lead developer: REVA Medical
Modality: Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration: Percutaneous

Overview

Fantom Encore is a third-generation sirolimus-eluting bioresorbable scaffold (BRS) developed by REVA Medical for the treatment of coronary artery disease. It is constructed from Tyrocore, a proprietary, radiopaque, tyrosine-derived polymer that allows for full visibility under X-ray without the need for platinum markers. The device features thin struts (95-115 μm) and is designed to provide temporary mechanical support to the coronary artery during the healing process before being fully resorbed by the body over a period of 36 to 48 months. The scaffold elutes sirolimus, an antiproliferative agent, to prevent neointimal hyperplasia and restenosis. It received CE Mark approval in 2018 as an alternative to permanent metallic drug-eluting stents.

Brand names: Fantom Encore
Other names: Fantom Encore BRSFantom Encore Sirolimus-Eluting Bioresorbable Scaffold

Targets

Mechanistic target of rapamycin complex 1

Beyond the preview

Go deeper on Fantom Encore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fantom Encore.

Explore the full profile